As emphasized by Pardo et al. [1], the concept of ion channels and pumps as cancer targets has recently gained considerable attention, and the Na+/K+-ATPase (the Na/K pump, i.e., NaK) could be targeted to combat chemoresistant cancers [2-4]. The gene discussed is TBK1; the disease is cancer.